ArticleTechnology and health care : official journal of the European Society for Engineering and Medicine2023
Construction of U-Net++ pulmonary nodule intelligent analysis model based on feature weighted aggregation.
Article in Technology and health care : official journal of the European Society for Engineering and Medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 6 citations in OpenAlex.
- Amplified TPM1 suppresses non-small cell lung cancer cells proliferation and metastasis.Discover oncology · 2025Article
- Value of CT diagnostic techniques based on imaging post-processing systems in the early diagnosis and treatment of lung cancer.American journal of translational research · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundLung cancer is a malignant tumor originating from the bronchial mucosa or glands of the lung. Early lung cancer patients often have no obvious symptoms, but early detection and treatment have an important clinical significance for prognostic effect. Computed tomography (CT) is one of the important means in the diagnosis of lung cancer. In order to better solve the problem of diagnosis efficiency, and reduce the rate of misdiagnosis and missed diagnosis, computer aided diagnosis are employed in the accurate localization and segmentation of pulmonary nodules through imaging diagnostics, image processing technology, and other clinical means.
objectiveThis present study was envisaged to establish an intelligent segmentation model of pulmonary nodules to improve the accuracy of early screening for lung cancer patients.
methodsCompared with the traditional segmentation model of fully convolutional neural network, the U-Net++ algorithm based on feature-weighted integration (WI-U-Net++) effectively utilized the feature weight information, adopted the adaptive weighted method for weighted integration, and performed an intelligent segmentation of the anatomical structure and image details, which was applied in the auxiliary diagnosis of pulmonary nodules in CT images. Standard chest X-ray phantom was selected as CT scanning objects, and 30 spherical and irregular simulated nodules were built into them, respectively. CT images were collected by setting different tube voltage and noise index, and randomly included into the training set, validation set and test set at a ratio of 8:1:1.
resultsThe experimental results showed that the segmentation accuracy of WI-U-Net++ algorithm for spheroid nodules and irregular nodules was 98.75% and 83.47%, respectively, which was better than that of U-Net and U-Net++ algorithm. In the auxiliary diagnosis, the recall rate of the WI-U-Net++ algorithm for spheroid nodules and irregular nodules was 93.47% and 84.52%, respectively. The accuracy of the benign or malignant identification was 80.27%, and the AUC was 0.9342.
conclusionU-Net++ algorithm based on feature-weighted integration could improve the segmentation effect of pulmonary nodules. Especially in the case of irregular nodules with malignant signs, the accuracy of clinical diagnosis was significantly improved, and the level of differential diagnosis between benign and malignant was improved.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.